유아 분유 시장 규모, 점유율, 성장률 및 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of infant formula Market

The global infant formula market was valued at USD 87.75 billion in 2025 and is projected to grow to USD 96.64 billion in 2026. By 2034, the market is expected to reach USD 207.52 billion, registering a CAGR of 10.02% during 2026-2034.

Asia Pacific dominated the global market in 2025, accounting for USD 60.49 billion, representing the largest regional share. The growth is driven by rising urbanization, increasing birth rates, expanding middle-class population, and growing awareness regarding infant nutrition.

Infant formula refers to specially designed nutritional products formulated for infants below one year of age. Regulatory bodies such as FSSAI, WHO, and FDA impose strict quality standards, which enhance consumer trust and product reliability.

Market Dynamics

Market Drivers

Hectic Lifestyles and Product Innovation

Urbanization and rising female workforce participation have significantly increased demand for convenient infant nutrition products. Working parents prefer nutritionally balanced formulas that ensure proper growth and development.

Major companies are investing heavily in research and innovation. For instance, Abbott invested USD 500 million in 2022 to expand manufacturing capacity in the U.S. Similarly, Danone introduced dairy-plant blend formulas to meet vegetarian and flexitarian demand.

Rising Awareness of Early Nutrition

Parents increasingly understand the importance of adequate nutrition in early childhood to prevent deficiencies and strengthen immunity. Growing concerns about vitamin deficiencies and immune health have encouraged demand for fortified formulas enriched with DHA, probiotics, and vitamins D, A, E, and C.

Market Trends

Shift Toward Clean-Label and Plant-Based Products

Consumers are increasingly demanding organic, clean-label, and plant-based infant formula. The market is witnessing innovation in probiotics, human milk oligosaccharides (HMOs), and vitamin-D fortification.

In 2023, Nestle launched a new infant formula in Hong Kong with enhanced nutritional blends to support bone, digestive, and cognitive development. The clean-label movement is particularly strong in developed markets across North America and Europe.

Market Restraints

Stringent Regulations and Safety Concerns

The industry faces strict regulatory scrutiny regarding product formulation and safety approvals. Product recalls, such as the 2023 recall of Enfamil ProSobee due to contamination concerns, highlight the sensitivity of the sector.

Additionally, increasing global breastfeeding rates-reaching 48% globally according to UNICEF and WHO-pose competitive pressure to formula products.

Segmentation Analysis

By Type

The market is segmented into infant milk, follow-on milk, and others.

• Infant Milk is projected to dominate with 43.98% market share in 2026, driven by high retail availability and consumer preference.
• Follow-on milk is expected to register a higher CAGR due to rising demand from working mothers and product diversification.

By Distribution Channel

The market is segmented into hypermarkets/supermarkets, pharmacy/medical stores, specialty stores, and others (including online).

• Hypermarkets/Supermarkets are projected to lead with 41.85% share in 2026, supported by product variety and accessibility.
• Online channels are expected to grow rapidly due to e-commerce expansion and fast delivery services.

Regional Analysis

Asia Pacific

• Market Size 2025: USD 60.49 Billion
• Largest global market

China leads the region, supported by high population and removal of the one-child policy. By 2026:

• China: USD 46.49 billion
• Japan: USD 2.83 billion
• India: USD 3.37 billion

Rising awareness, growing disposable income, and innovation in DHA-based products support growth.

North America

The U.S. infant formula market is projected to reach USD 5.77 billion in 2026 and is forecasted to reach USD 10.22 billion by 2032. Government efforts to ease imports and high awareness among parents regarding premium nutrition are driving growth.

Europe

Europe shows steady growth driven by demand for organic and plant-based products.

• UK market: USD 1.67 billion in 2026
• Germany market: USD 1.70 billion in 2026

Innovation by companies such as Nestle and Danone strengthens the regional market.

South America

Rapid urbanization and economic growth in Brazil and Argentina are driving demand. Rising household consumption and population growth contribute to market expansion.

Middle East & Africa

Improving infrastructure, urbanization, and economic development are expected to boost infant formula demand in the region over the forecast period.

Competitive Landscape

The market is moderately consolidated, with key players focusing on product innovation, organic variants, and base expansion strategies.

Key Companies:

• Nestle S.A.
• Danone S.A.
• Arla Foods
• Yili Group
• Abbott
• Perrigo Company plc
• Reckitt Benckiser Group PLC
• FrieslandCampina
• Bellamy's Organic
• The Kraft Heinz Company

Strategic investments, acquisitions, and product fortification remain key growth strategies.

Conclusion

The global infant formula market is set for strong expansion, growing from USD 87.75 billion in 2025 to USD 207.52 billion by 2034, supported by rising awareness of infant nutrition, increasing working women population, urbanization, and innovation in clean-label and plant-based formulations. Although regulatory challenges and breastfeeding trends may moderate growth, strong demand in Asia Pacific and continued R&D investments by leading companies will sustain steady market expansion throughout the forecast period.

Segmentation By Type

• Infant Milk
• Follow-On-Milk
• Others

By Distribution Channel

• Hypermarkets/ Supermarkets
• Pharmacy/Medical Stores
• Specialty Stores
• Others

By Geography

• North America (By Type, Distribution Channel, and By Country)
  • U.S. (By Distribution Channel)
  • Canada (By Distribution Channel)
  • Mexico (By Distribution Channel)
• Europe (By Type, Distribution Channel, and By Country)
  • Germany (By Distribution Channel)
  • France (By Distribution Channel)
  • Italy (By Distribution Channel)
  • Spain (By Distribution Channel)
  • U.K. (By Distribution Channel)
  • Russia (By Distribution Channel)
  • Rest of Europe (By Distribution Channel)
• Asia Pacific (By Type, Distribution Channel, and By Country)
  • China (By Distribution Channel)
  • India (By Distribution Channel)
  • Japan (By Distribution Channel)
  • Australia (By Distribution Channel)
  • South Korea (By Distribution Channel)
  • Rest of Asia Pacific (By Distribution Channel)
• South America (By Type, Distribution Channels, and By Country)
  • Brazil (By Distribution Channel)
  • Argentina (By Distribution Channel)
  • Rest of South America (By Distribution Channel)
• Middle East & Africa (By Type, Distribution Channel, and By Country)
  • South Africa (By Distribution Channel)
  • Saudi Arabia (By Distribution Channel)
  • Rest of the Middle East & Africa (By Distribution Channel)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Overview on the Parent Market
• 4.2. Supply Chain Analysis
• 4.3. Industry SWOT Analysis
• 4.4. Regulatory Framework
• 4.5. Recent Industry Developments - Policies, Mergers & Acquisitions, and New Product Launches
• 4.6. Market Analysis and Insights (in Relation with COVID-19)
  • 4.6.1. Impact of COVID-19 on the Market
  • 4.6.2. Supply Chain Challenges due to the Pandemic
  • 4.6.3. Potential Opportunities Due to COVID-19

5. Global Infant Formula Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Size Estimates and Forecast
  • 5.2.1. By Type (Value)
    • 5.2.1.1. Infant Milk
    • 5.2.1.2. Follow-On Milk
    • 5.2.1.3. Others
  • 5.2.2. By Distribution Channel (Value)
    • 5.2.2.1. Hypermarkets/Supermarkets
    • 5.2.2.2. Pharmacy/Medical Stores
    • 5.2.2.3. Specialty Stores
    • 5.2.2.4. Others
  • 5.2.3. By Region (Value)
    • 5.2.3.1. North America
    • 5.2.3.2. Europe
    • 5.2.3.3. Asia Pacific
    • 5.2.3.4. South America
    • 5.2.3.5. Middle East & Africa

6. North America Infant Formula Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Size Estimates and Forecast
  • 6.2.1. By Type (Value)
    • 6.2.1.1. Infant Milk
    • 6.2.1.2. Follow-On Milk
    • 6.2.1.3. Others
  • 6.2.2. By Distribution Channel (Value)
    • 6.2.2.1. Hypermarkets/Supermarkets
    • 6.2.2.2. Pharmacy/Medical Stores
    • 6.2.2.3. Specialty Stores
    • 6.2.2.4. Others
  • 6.2.3. By Country (Value)
    • 6.2.3.1. U.S.
      • 6.2.3.1.1. By Distribution Channel (Value)
        • 6.2.3.1.1.1. Hypermarkets/Supermarkets
        • 6.2.3.1.1.2. Pharmacy/Medical Stores
        • 6.2.3.1.1.3. Specialty Stores
        • 6.2.3.1.1.4. Others
    • 6.2.3.2. Canada
      • 6.2.3.2.1. By Distribution Channel (Value)
        • 6.2.3.2.1.1. Hypermarkets/Supermarkets
        • 6.2.3.2.1.2. Pharmacy/Medical Stores
        • 6.2.3.2.1.3. Specialty Stores
        • 6.2.3.2.1.4. Others
    • 6.2.3.3. Mexico
      • 6.2.3.3.1. By Distribution Channel (Value)
        • 6.2.3.3.1.1. Hypermarkets/Supermarkets
        • 6.2.3.3.1.2. Pharmacy/Medical Stores
        • 6.2.3.3.1.3. Specialty Stores
        • 6.2.3.3.1.4. Others

7. Europe Infant Formula Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Size Estimates and Forecast
  • 7.2.1. By Type (Value)
    • 7.2.1.1. Infant Milk
    • 7.2.1.2. Follow-On Milk
    • 7.2.1.3. Others
  • 7.2.2. By Distribution Channel (Value)
    • 7.2.2.1. Hypermarkets/Supermarkets
    • 7.2.2.2. Pharmacy/Medical Stores
    • 7.2.2.3. Specialty Stores
    • 7.2.2.4. Others
  • 7.2.3. By Country (Value)
    • 7.2.3.1. Germany
      • 7.2.3.1.1. By Distribution Channel (Value)
        • 7.2.3.1.1.1. Hypermarkets/Supermarkets
        • 7.2.3.1.1.2. Pharmacy/Medical Stores
        • 7.2.3.1.1.3. Specialty Stores
        • 7.2.3.1.1.4. Others
    • 7.2.3.2. U.K.
      • 7.2.3.2.1. By Distribution Channel (Value)
        • 7.2.3.2.1.1. Hypermarkets/Supermarkets
        • 7.2.3.2.1.2. Pharmacy/Medical Stores
        • 7.2.3.2.1.3. Specialty Stores
        • 7.2.3.2.1.4. Others
    • 7.2.3.3. France
      • 7.2.3.3.1. By Distribution Channel (Value)
        • 7.2.3.3.1.1. Hypermarkets/Supermarkets
        • 7.2.3.3.1.2. Pharmacy/Medical Stores
        • 7.2.3.3.1.3. Specialty Stores
        • 7.2.3.3.1.4. Others
    • 7.2.3.4. Italy
      • 7.2.3.4.1. By Distribution Channel (Value)
        • 7.2.3.4.1.1. Hypermarkets/Supermarkets
        • 7.2.3.4.1.2. Pharmacy/Medical Stores
        • 7.2.3.4.1.3. Specialty Stores
        • 7.2.3.4.1.4. Others
    • 7.2.3.5. Spain
      • 7.2.3.5.1. By Distribution Channel (Value)
        • 7.2.3.5.1.1. Hypermarkets/Supermarkets
        • 7.2.3.5.1.2. Pharmacy/Medical Stores
        • 7.2.3.5.1.3. Specialty Stores
        • 7.2.3.5.1.4. Others
    • 7.2.3.6. Russia
      • 7.2.3.6.1. By Distribution Channel (Value)
        • 7.2.3.6.1.1. Hypermarkets/Supermarkets
        • 7.2.3.6.1.2. Pharmacy/Medical Stores
        • 7.2.3.6.1.3. Specialty Stores
        • 7.2.3.6.1.4. Others
    • 7.2.3.7. Rest of Europe
      • 7.2.3.7.1. By Distribution Channel (Value)
        • 7.2.3.7.1.1. Hypermarkets/Supermarkets
        • 7.2.3.7.1.2. Pharmacy/Medical Stores
        • 7.2.3.7.1.3. Specialty Stores
        • 7.2.3.7.1.4. Others

8. Asia Pacific Infant Formula Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
  • 8.1.1. By Type (Value)
    • 8.1.1.1. Infant Milk
    • 8.1.1.2. Follow-On Milk
    • 8.1.1.3. Others
  • 8.1.2. By Distribution Channel (Value)
    • 8.1.2.1. Hypermarkets/Supermarkets
    • 8.1.2.2. Pharmacy/Medical Stores
    • 8.1.2.3. Specialty Stores
    • 8.1.2.4. Others
  • 8.1.3. By Country (Value)
    • 8.1.3.1. China
      • 8.1.3.1.1. By Distribution Channel (Value)
        • 8.1.3.1.1.1. Hypermarkets/Supermarkets
        • 8.1.3.1.1.2. Pharmacy/Medical Stores
        • 8.1.3.1.1.3. Specialty Stores
        • 8.1.3.1.1.4. Others
    • 8.1.3.2. India
      • 8.1.3.2.1. By Distribution Channel (Value)
        • 8.1.3.2.1.1. Hypermarkets/Supermarkets
        • 8.1.3.2.1.2. Pharmacy/Medical Stores
        • 8.1.3.2.1.3. Specialty Stores
        • 8.1.3.2.1.4. Others
    • 8.1.3.3. Japan
      • 8.1.3.3.1. By Distribution Channel (Value)
        • 8.1.3.3.1.1. Hypermarkets/Supermarkets
        • 8.1.3.3.1.2. Pharmacy/Medical Stores
        • 8.1.3.3.1.3. Specialty Stores
        • 8.1.3.3.1.4. Others
    • 8.1.3.4. Australia
      • 8.1.3.4.1. By Distribution Channel (Value)
        • 8.1.3.4.1.1. Hypermarkets/Supermarkets
        • 8.1.3.4.1.2. Pharmacy/Medical Stores
        • 8.1.3.4.1.3. Specialty Stores
        • 8.1.3.4.1.4. Others
    • 8.1.3.5. Rest of APAC
      • 8.1.3.5.1. By Distribution Channel (Value)
        • 8.1.3.5.1.1. Hypermarkets/Supermarkets
        • 8.1.3.5.1.2. Pharmacy/Medical Stores
        • 8.1.3.5.1.3. Specialty Stores
        • 8.1.3.5.1.4. Others

9. South America Infant Formula Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
  • 9.1.1. By Type (Value)
    • 9.1.1.1. Infant Milk
    • 9.1.1.2. Follow-On Milk
    • 9.1.1.3. Others
  • 9.1.2. By Distribution Channel (Value)
    • 9.1.2.1. Hypermarkets/Supermarkets
    • 9.1.2.2. Pharmacy/Medical Stores
    • 9.1.2.3. Specialty Stores
    • 9.1.2.4. Others
  • 9.1.3. By Country (Value)
    • 9.1.3.1. Brazil
      • 9.1.3.1.1. By Distribution Channel (Value)
        • 9.1.3.1.1.1. Hypermarkets/Supermarkets
        • 9.1.3.1.1.2. Pharmacy/Medical Stores
        • 9.1.3.1.1.3. Specialty Stores
        • 9.1.3.1.1.4. Others
    • 9.1.3.2. Argentina
      • 9.1.3.2.1. By Distribution Channel (Value)
        • 9.1.3.2.1.1. Hypermarkets/Supermarkets
        • 9.1.3.2.1.2. Pharmacy/Medical Stores
        • 9.1.3.2.1.3. Specialty Stores
        • 9.1.3.2.1.4. Others
    • 9.1.3.3. Rest of South America
      • 9.1.3.3.1. By Distribution Channel (Value)
        • 9.1.3.3.1.1. Hypermarkets/Supermarkets
        • 9.1.3.3.1.2. Pharmacy/Medical Stores
        • 9.1.3.3.1.3. Specialty Stores
        • 9.1.3.3.1.4. Others

10. Middle East and Africa Infant Formula Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
  • 10.1.1. By Type (Value)
    • 10.1.1.1. Infant Milk
    • 10.1.1.2. Follow-On Milk
    • 10.1.1.3. Others
  • 10.1.2. By Distribution Channel (Value)
    • 10.1.2.1. Hypermarkets/Supermarkets
    • 10.1.2.2. Pharmacy/Medical Stores
    • 10.1.2.3. Specialty Stores
    • 10.1.2.4. Others
  • 10.1.3. By Country (Value)
    • 10.1.3.1. South Africa
      • 10.1.3.1.1. By Distribution Channel (Value)
        • 10.1.3.1.1.1. Hypermarkets/Supermarkets
        • 10.1.3.1.1.2. Pharmacy/Medical Stores
        • 10.1.3.1.1.3. Specialty Stores
        • 10.1.3.1.1.4. Others
    • 10.1.3.2. UAE
      • 10.1.3.2.1. By Distribution Channel (Value)
        • 10.1.3.2.1.1. Hypermarkets/Supermarkets
        • 10.1.3.2.1.2. Pharmacy/Medical Stores
        • 10.1.3.2.1.3. Specialty Stores
        • 10.1.3.2.1.4. Others
    • 10.1.3.3. Rest of ME&A
      • 10.1.3.3.1. By Distribution Channel (Value)
        • 10.1.3.3.1.1. Hypermarkets/Supermarkets
        • 10.1.3.3.1.2. Pharmacy/Medical Stores
        • 10.1.3.3.1.3. Specialty Stores
        • 10.1.3.3.1.4. Others

11. Competitive Matrix

• 11.1. Business Strategies Adopted by Leading Players
• 11.2. Global Infant Formula Market Revenue Share/Ranking Analysis, By Key Manufacturer, 2025

12. Company Profiles

• 12.1. Nestle S.A.
  • 12.1.1. Overview
  • 12.1.2. Description
  • 12.1.3. Type Portfolio
  • 12.1.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.1.5. Recent Developments
• 12.2. Danone S.A.
  • 12.2.1. Overview
  • 12.2.2. Description
  • 12.2.3. Type Portfolio
  • 12.2.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.2.5. Recent Developments
• 12.3. Arla Foods
  • 12.3.1. Overview
  • 12.3.2. Description
  • 12.3.3. Type Portfolio
  • 12.3.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.3.5. Recent Developments
• 12.4. Yili Group
  • 12.4.1. Overview
  • 12.4.2. Description
  • 12.4.3. Type Portfolio
  • 12.4.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.4.5. Recent Developments
• 12.5. Abbott
  • 12.5.1. Overview
  • 12.5.2. Description
  • 12.5.3. Type Portfolio
  • 12.5.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.5.5. Recent Developments
• 12.6. The Kraft Heinz Company
  • 12.6.1. Overview
  • 12.6.2. Description
  • 12.6.3. Type Portfolio
  • 12.6.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.6.5. Recent Developments
• 12.7. Bellamy's Organic
  • 12.7.1. Overview
  • 12.7.2. Description
  • 12.7.3. Type Portfolio
  • 12.7.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.7.5. Recent Developments
• 12.8. Reckitt Benckiser Group PLC
  • 12.8.1. Overview
  • 12.8.2. Description
  • 12.8.3. Type Portfolio
  • 12.8.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.8.5. Recent Developments
• 12.9. Perrigo Company plc
  • 12.9.1. Overview
  • 12.9.2. Description
  • 12.9.3. Type Portfolio
  • 12.9.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.9.5. Recent Developments
• 12.10. FrieslandCampina
  • 12.10.1. Overview
  • 12.10.2. Description
  • 12.10.3. Type Portfolio
  • 12.10.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.10.5. Recent Developments

13. Strategic Recommendations

14. Appendix